Basic Information
Stylus Medicine is a biotechnology company developing in vivo gene therapies to unlock treatment possibilities. The company provides genome engineering and chromatin modulation technologies for the development of enzyme and drug delivery methods, enabling targeted in vivo gene editing. This allows customers to insert gene sequences of any length into the human genome, facilitating the development of permanent treatments for patients.
Stylus Medicine, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2022
--

